« Back to Record
Lalami, Y., Specenier, P. M., Awada, A., Lacombe, D., Liberatoscioli, C., Fortpied, C., El-Hariry, I., Bogaerts, J., Andry, G., Langendijk, J. A., & Vermorken, J. B. (2012). EORTC 24051: unexpected side effects in a phase I study of TPF induction chemotherapy followed by chemoradiation with lapatinib, a dual EGFR/ErbB2 inhibitor, in patients with locally advanced resectable larynx and hypopharynx squamous cell carcinoma. Radiotherapy and oncology, 105(2), 238-240. doi:10.1016/j.radonc.2012.08.006
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/144706



